metaproterenol has been researched along with Cystic Fibrosis in 2 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Response to the inhaled bronchodilator, metaproterenol, was evaluated in 28 outpatient infants and young children with cystic fibrosis (CF) (mean age, 16 months) and in 22 normal control children (mean age, 13 months)." | 3.67 | Bronchodilator responsiveness in infants and young children with cystic fibrosis. ( Eigen, H; Hiatt, P; Tepper, RS; Yu, P, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weintraub, SJ | 1 |
| Eschenbacher, WL | 1 |
| Hiatt, P | 1 |
| Eigen, H | 1 |
| Yu, P | 1 |
| Tepper, RS | 1 |
1 trial available for metaproterenol and Cystic Fibrosis
| Article | Year |
|---|---|
The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF.
Topics: Administration, Inhalation; Adult; Atropine Derivatives; Clinical Trials as Topic; Cystic Fibrosis; | 1989 |
1 other study available for metaproterenol and Cystic Fibrosis
| Article | Year |
|---|---|
Bronchodilator responsiveness in infants and young children with cystic fibrosis.
Topics: Child, Preschool; Cystic Fibrosis; Female; Functional Residual Capacity; Humans; Infant; Lung; Male; | 1988 |